Astria Therapeutics, Inc. (NasdaqGM: ATXS)
Health Care · Biotechnology · US
$—
0.00% today · — 1Y
Astria Therapeutics, Inc. (NasdaqGM: ATXS) operates in the Biotechnology industry within the Health Care sector.
trading between 6.09 and 13.29.
Tweenvest scores Astria Therapeutics, Inc. across four factors: quality 30/100, value 55/100. Its strongest factor is value.
ATXS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $706.00K
- P/E
- —
- EPS
- -2.14
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $13.29
- 52-week low
- $6.09
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 78
- Next earnings
- —
About Astria Therapeutics, Inc.
Astria Therapeutics, Inc. is a biopharmaceutical company based in Boston, Massachusetts, established in 2008. The firm specializes in identifying, advancing, and bringing to market treatments for uncommon and specialized allergic and immunological disorders across the United States. Its leading experimental drug, STAR-0215, is a monoclonal antibody that targets and inhibits plasma kallikrein. This candidate is presently undergoing preclinical development to address hereditary angioedema. The company adopted its current name, Astria Therapeutics, Inc., in September 2021, having previously operated as Catabasis Pharmaceuticals, Inc.
- ISIN
- US04635X1028
- Founded
- 2008
- Listed since
- Jun 25, 2015
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.